FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2306767579> ?p ?o ?g. }

• W2306767579 endingPage "397" @default.
• W2306767579 startingPage "389" @default.
• W2306767579 abstract "No endpoint (EP) has yet been recognized as a surrogate of overall survival (OS) after systemic treatment in patients with metastatic castration-resistant prostate cancer (mCRPC). The aim of the present report was to suggest, using a trial-level analysis, what might be the most appropriate EPs for trials of new drugs for patients with mCRPC.A literature search of randomized trials of medical treatments in patients with mCRPC was undertaken. The response-related and time-to-event EPs were evaluated. For each trial, the differences in OS and the examined EPs between the experimental and control arms and a correlation coefficient for every relationship were calculated. An additional regression analysis was performed to determine the proportion of variability explained (R2trial) on OS for the most frequently reported EPs in the selected trials.A total of 28 studies were included in the present analysis. Correlation analyses documented a significant relationship between the prostate-specific antigen (PSA)-related response rate and OS. Although not significant, a strong correlation coefficient was found for the relationship of radiologic progression-free survival (PFS) and OS and of PSA-related PFS and OS. The strength of the relationships with OS for all 3 EPs was greater among the trials published from 2005 to 2014.The PSA response rate and radiologic PFS reported greater rates of correlation with OS among trials of medical treatments of mCRPC, in particular, in studies published in the past 10 years. Both PSA and PFS should be evaluated for surrogacy at an individual level in large prospective trials of medical treatments for patients with mCRPC." @default.
• W2306767579 created "2016-06-24" @default.
• W2306767579 creator A5000322332 @default.
• W2306767579 creator A5019303506 @default.
• W2306767579 creator A5046259040 @default.
• W2306767579 date "2016-10-01" @default.
• W2306767579 modified "2023-09-24" @default.
• W2306767579 title "Trial Level Analysis of Prostate-Specific Antigen-Related Versus Unrelated Endpoints in Phase III Trials of First-Line and Second-Line Medical Treatments of Patients With Metastatic Castration-Resistant Prostate Cancer" @default.
• W2306767579 cites W1854708637 @default.
• W2306767579 cites W1868905893 @default.
• W2306767579 cites W1891088877 @default.
• W2306767579 cites W1893347245 @default.
• W2306767579 cites W1972912578 @default.
• W2306767579 cites W1997327310 @default.
• W2306767579 cites W2023421823 @default.
• W2306767579 cites W2049715100 @default.
• W2306767579 cites W2075642745 @default.
• W2306767579 cites W2080439368 @default.
• W2306767579 cites W2110534364 @default.
• W2306767579 cites W2113046540 @default.
• W2306767579 cites W2114875729 @default.
• W2306767579 cites W2117296712 @default.
• W2306767579 cites W2118370975 @default.
• W2306767579 cites W2120292596 @default.
• W2306767579 cites W2123526148 @default.
• W2306767579 cites W2124670562 @default.
• W2306767579 cites W2125942853 @default.
• W2306767579 cites W2126251787 @default.
• W2306767579 cites W2128373662 @default.
• W2306767579 cites W2128628205 @default.
• W2306767579 cites W2130626169 @default.
• W2306767579 cites W2130803372 @default.
• W2306767579 cites W2132611552 @default.
• W2306767579 cites W2137467802 @default.
• W2306767579 cites W2145608595 @default.
• W2306767579 cites W2148643283 @default.
• W2306767579 cites W2150568050 @default.
• W2306767579 cites W2151232297 @default.
• W2306767579 cites W2157549109 @default.
• W2306767579 cites W2160129915 @default.
• W2306767579 cites W2160316498 @default.
• W2306767579 cites W2161193168 @default.
• W2306767579 cites W2161306413 @default.
• W2306767579 cites W2165088640 @default.
• W2306767579 cites W2165542862 @default.
• W2306767579 cites W2166918329 @default.
• W2306767579 cites W2167331614 @default.
• W2306767579 cites W2168167318 @default.
• W2306767579 cites W2169700609 @default.
• W2306767579 cites W2171230974 @default.
• W2306767579 cites W2172250854 @default.
• W2306767579 doi "https://doi.org/10.1016/j.clgc.2016.03.022" @default.
• W2306767579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27108003" @default.
• W2306767579 hasPublicationYear "2016" @default.
• W2306767579 type Work @default.
• W2306767579 sameAs 2306767579 @default.
• W2306767579 citedByCount "5" @default.
• W2306767579 countsByYear W23067675792019 @default.
• W2306767579 countsByYear W23067675792020 @default.
• W2306767579 countsByYear W23067675792021 @default.
• W2306767579 countsByYear W23067675792022 @default.
• W2306767579 countsByYear W23067675792023 @default.
• W2306767579 crossrefType "journal-article" @default.
• W2306767579 hasAuthorship W2306767579A5000322332 @default.
• W2306767579 hasAuthorship W2306767579A5019303506 @default.
• W2306767579 hasAuthorship W2306767579A5046259040 @default.
• W2306767579 hasConcept C121608353 @default.
• W2306767579 hasConcept C126322002 @default.
• W2306767579 hasConcept C141341695 @default.
• W2306767579 hasConcept C143998085 @default.
• W2306767579 hasConcept C168563851 @default.
• W2306767579 hasConcept C203092338 @default.
• W2306767579 hasConcept C2776235491 @default.
• W2306767579 hasConcept C2780192828 @default.
• W2306767579 hasConcept C2781406297 @default.
• W2306767579 hasConcept C535046627 @default.
• W2306767579 hasConcept C71924100 @default.
• W2306767579 hasConceptScore W2306767579C121608353 @default.
• W2306767579 hasConceptScore W2306767579C126322002 @default.
• W2306767579 hasConceptScore W2306767579C141341695 @default.
• W2306767579 hasConceptScore W2306767579C143998085 @default.
• W2306767579 hasConceptScore W2306767579C168563851 @default.
• W2306767579 hasConceptScore W2306767579C203092338 @default.
• W2306767579 hasConceptScore W2306767579C2776235491 @default.
• W2306767579 hasConceptScore W2306767579C2780192828 @default.
• W2306767579 hasConceptScore W2306767579C2781406297 @default.
• W2306767579 hasConceptScore W2306767579C535046627 @default.
• W2306767579 hasConceptScore W2306767579C71924100 @default.
• W2306767579 hasIssue "5" @default.
• W2306767579 hasLocation W23067675791 @default.
• W2306767579 hasLocation W23067675792 @default.
• W2306767579 hasOpenAccess W2306767579 @default.
• W2306767579 hasPrimaryLocation W23067675791 @default.
• W2306767579 hasRelatedWork W139932918 @default.
• W2306767579 hasRelatedWork W1672944621 @default.
• W2306767579 hasRelatedWork W2017132929 @default.
• W2306767579 hasRelatedWork W2268282789 @default.
• W2306767579 hasRelatedWork W2604409474 @default.

• next